Skip to main content
KALA
NASDAQ Life Sciences

KALA BIO Cuts Quarterly Net Loss ~90% to $0.8M, Ends Quarter With $7M Cash and No Debt

Tom Rudovsky · Reported by TMX Newsfile
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.157
Mkt Cap
$3.015M
52W Low
$0.115
52W High
$95.5
52W Position info
37% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

KALA sits 37% above its 52-week low of $0.115 on light trading volume (0.1× avg).

Summary

KALA BIO reported a preliminary third-quarter net loss of about $0.8 million, down from $7.6 million a year earlier — roughly a 90% reduction, per CEO Avi Minkowitz. The nine-month loss narrowed to about $4.0 million from $27.7 million. The company ended September 30 with roughly $7.0 million in cash, cash equivalents and short-term investments and no debt, a sharp improvement from the sub-$0.1 million cash position disclosed in the Q2 10-Q. That cash figure matters most here: the company has a Nasdaq delisting determination outstanding and shareholder authority for a reverse split of 1-for-2 up to 1-for-300 approved at the November 3 annual meeting. The numbers are unaudited and preliminary; the full 10-Q is expected on or about November 16, 2026.

At the time of this announcement, KALA was trading at $0.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3M. The 52-week trading range was $0.11 to $95.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.


Price Chart

Share this article

Copied!

KALA - Latest Insights

KALA
Sep 29, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.474
Real-time Price: $0.170 info
Change: -$0.304 (-64%) info
Market Cap: $3.429M info
KALA
Sep 24, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.5288
Real-time Price: $0.170 info
Change: -$0.3588 (-68%) info
Market Cap: $3.429M info
KALA
Sep 11, 2026, 4:56 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.590
Real-time Price: $0.170 info
Change: -$0.420 (-71%) info
Market Cap: $3.429M info
KALA
Sep 03, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.538
Real-time Price: $0.170 info
Change: -$0.368 (-68%) info
Market Cap: $3.429M info
KALA
Aug 28, 2026, 6:45 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.795
Real-time Price: $0.170 info
Change: -$0.625 (-79%) info
Market Cap: $3.429M info